JAMA Otol Logo Orlando 2013 AHNS Meeting Location
American Head & Neck Society
Annual Meeting, April 10-11, 2013
JW Marriott Grande Lakes
Orlando, Florida

During the
Combined Otolaryngology Spring Meeting
Tips on Using this Site
Locate an abstract by entering any author's surname into the search box.

Broaden your search by typing only a few letters of a keyword; do not append the wildcard “*” to a search string.

Type too small? In most browsers, press Control “+” to enlarge type size. Reset by pressing Control “0”.

Results. To view an abstract, click on a title within results. Presenters’ names are underlined among the list of authors.

Presentation: S020
Topic: Clinical - Novel Technology
Type: Oral Presentation
Date: Thursday, April 11, 2013
Session: 08:00 AM - 09:00 AM Thyroid / General
Authors: Hunter Faircloth, BS, Don Mettenberg, AS, Aaron Cunningham, BS, Matt Jones, MSECE, Madelaine Dubin, Frederick Rueggeberg, DDS, Gregory Postma, MD, Paul Weinberger, MD
Institution(s): Georgia Health Sciences University

BACKGROUND: Patients with large segment tracheal disease from benign processes or cancer (thyroid or squamous cell) have limited treatment options. Reconstruction of large-segment tracheal defects is difficult, and allograft transplantation with the requisite immunosuppression is not an option in patients with active malignancy. Regenerative medicine may offer a viable alternative. In 2008, a trachea was grown in an experimental bioreactor from a patient’s own stem cells and successfully transplanted. Problems encountered with this process include inability to sterilize the bioreactor, implementation barriers of scale, and potential cross-contamination between repeated use the bioreactor vessel.
The purpose of this study was to design a second-generation bioreactor that could potentially be implemented in a wide variety of end-user clinical locations.

METHODS: We used computer aided design / computer aided manufacturing (CAD-CAM) coupled with a custom-built 3-D printing device capable of directly fabricating design components to construct a prototype second-generation bioreactor. Essential design elements included the following: 1) A two chamber system allowing for separate growth media conditions for the luminal (epithelial cells) and external (chondrocytes) graft surfaces. 2) Controlled rotation at 1 RPM to induce optimal fluid shear forces to induce chondrogenic differentiation and growth. 3) Continuous carbon-dioxide and oxygen gas exchange. 4) Single-use modular design, where the bioreactor vessel can be pre-sterilized and individually packaged. 5) Easy media exchange if required during graft culturing. The bioreactor prototype was constructed using polylactic acid (PLA), to minimize any potential biocompatibility issues.

RESULTS: The CAD-CAM system allowed rapid turnaround time (2-7 days) between iterative design changes. We successfully fabricated a final prototype bioreactor meeting all design requirements. The prototype uses a novel “rock-tumbler” based approach where the sterile chamber is essentially a modular, single use cylinder-in-cylinder that can be pre-sterilized separate from the motor and gas exchange connectors.

CONCLUSION: Our next-generation bioreactor model has the potential to allow hollow-tube organ production at large scale. The ability to test in nearly real-time, the effects of various modifications was a unique advantage of using the 3D printing system. While initially designed for growth of stem-cell seeded trachea, it can easily be modified for future use in a variety of other applications, such as esophageal or vascular grafts. Owing to the modular design and “single-use cartridge” approach, use of stem-cell mediated regenerative techniques may eventually be feasible at a much broader range of clinical settings than previously thought possible.


paroxetin 1a pharma 20 mg ogvitaminerkob.site paroxetin serotonin

JAMA Network Logo